349 related articles for article (PubMed ID: 9892201)
1. hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability.
Leung SY; Yuen ST; Chung LP; Chu KM; Chan AS; Ho JC
Cancer Res; 1999 Jan; 59(1):159-64. PubMed ID: 9892201
[TBL] [Abstract][Full Text] [Related]
2. Correlation of methylation of the hMLH1 promoter with lack of expression of hMLH1 in sporadic gastric carcinomas with replication error.
Kang GH; Shim YH; Ro JY
Lab Invest; 1999 Jul; 79(7):903-9. PubMed ID: 10418831
[TBL] [Abstract][Full Text] [Related]
3. Concerted promoter hypermethylation of hMLH1, p16INK4A, and E-cadherin in gastric carcinomas with microsatellite instability.
Kim H; Kim YH; Kim SE; Kim NG; Noh SH; Kim H
J Pathol; 2003 May; 200(1):23-31. PubMed ID: 12692837
[TBL] [Abstract][Full Text] [Related]
4. [Methylation of hMLH1 gene promoter in gastric carcinoma with microsatellite instability].
Li JH; Shi XZ; Liu M; Wang Y; Yu ZH; Xu GW; Lu S
Ai Zheng; 2005 Mar; 24(3):273-7. PubMed ID: 15757526
[TBL] [Abstract][Full Text] [Related]
5. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability.
Cunningham JM; Christensen ER; Tester DJ; Kim CY; Roche PC; Burgart LJ; Thibodeau SN
Cancer Res; 1998 Aug; 58(15):3455-60. PubMed ID: 9699680
[TBL] [Abstract][Full Text] [Related]
6. Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability.
Fleisher AS; Esteller M; Wang S; Tamura G; Suzuki H; Yin J; Zou TT; Abraham JM; Kong D; Smolinski KN; Shi YQ; Rhyu MG; Powell SM; James SP; Wilson KT; Herman JG; Meltzer SJ
Cancer Res; 1999 Mar; 59(5):1090-5. PubMed ID: 10070967
[TBL] [Abstract][Full Text] [Related]
7. Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma.
Geisler JP; Goodheart MJ; Sood AK; Holmes RJ; Hatterman-Zogg MA; Buller RE
Cancer; 2003 Nov; 98(10):2199-206. PubMed ID: 14601090
[TBL] [Abstract][Full Text] [Related]
8. Microsatellite instability in inflammatory bowel disease-associated neoplastic lesions is associated with hypermethylation and diminished expression of the DNA mismatch repair gene, hMLH1.
Fleisher AS; Esteller M; Harpaz N; Leytin A; Rashid A; Xu Y; Liang J; Stine OC; Yin J; Zou TT; Abraham JM; Kong D; Wilson KT; James SP; Herman JG; Meltzer SJ
Cancer Res; 2000 Sep; 60(17):4864-8. PubMed ID: 10987299
[TBL] [Abstract][Full Text] [Related]
9. Hypermethylation of the hMLH1 gene promoter is associated with microsatellite instability in early human gastric neoplasia.
Fleisher AS; Esteller M; Tamura G; Rashid A; Stine OC; Yin J; Zou TT; Abraham JM; Kong D; Nishizuka S; James SP; Wilson KT; Herman JG; Meltzer SJ
Oncogene; 2001 Jan; 20(3):329-35. PubMed ID: 11313962
[TBL] [Abstract][Full Text] [Related]
10. Methylation of the hMLH1 promoter but no hMLH1 mutations in sporadic gastric carcinomas with high-level microsatellite instability.
Bevilacqua RA; Simpson AJ
Int J Cancer; 2000 Jul; 87(2):200-3. PubMed ID: 10861474
[TBL] [Abstract][Full Text] [Related]
11. Distinct patterns of KRAS mutations in colorectal carcinomas according to germline mismatch repair defects and hMLH1 methylation status.
Oliveira C; Westra JL; Arango D; Ollikainen M; Domingo E; Ferreira A; Velho S; Niessen R; Lagerstedt K; Alhopuro P; Laiho P; Veiga I; Teixeira MR; Ligtenberg M; Kleibeuker JH; Sijmons RH; Plukker JT; Imai K; Lage P; Hamelin R; Albuquerque C; Schwartz S; Lindblom A; Peltomaki P; Yamamoto H; Aaltonen LA; Seruca R; Hofstra RM
Hum Mol Genet; 2004 Oct; 13(19):2303-11. PubMed ID: 15294875
[TBL] [Abstract][Full Text] [Related]
12. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma.
Herman JG; Umar A; Polyak K; Graff JR; Ahuja N; Issa JP; Markowitz S; Willson JK; Hamilton SR; Kinzler KW; Kane MF; Kolodner RD; Vogelstein B; Kunkel TA; Baylin SB
Proc Natl Acad Sci U S A; 1998 Jun; 95(12):6870-5. PubMed ID: 9618505
[TBL] [Abstract][Full Text] [Related]
13. MSI-L gastric carcinomas share the hMLH1 methylation status of MSI-H carcinomas but not their clinicopathological profile.
Pinto M; Oliveira C; Machado JC; Cirnes L; Tavares J; Carneiro F; Hamelin R; Hofstra R; Seruca R; Sobrinho-Simões M
Lab Invest; 2000 Dec; 80(12):1915-23. PubMed ID: 11140703
[TBL] [Abstract][Full Text] [Related]
14. Methylation of the hMLH1 promoter in multiple gastric carcinomas with microsatellite instability.
Jung HY; Jung KC; Shim YH; Ro JY; Kang GH
Pathol Int; 2001 Jun; 51(6):445-51. PubMed ID: 11422806
[TBL] [Abstract][Full Text] [Related]
15. Methylation of hMLH1 in a population-based series of endometrial carcinomas.
Salvesen HB; MacDonald N; Ryan A; Iversen OE; Jacobs IJ; Akslen LA; Das S
Clin Cancer Res; 2000 Sep; 6(9):3607-13. PubMed ID: 10999752
[TBL] [Abstract][Full Text] [Related]
16. Hypermethylation of HPP1 is associated with hMLH1 hypermethylation in gastric adenocarcinomas.
Shibata DM; Sato F; Mori Y; Perry K; Yin J; Wang S; Xu Y; Olaru A; Selaru F; Spring K; Young J; Abraham JM; Meltzer SJ
Cancer Res; 2002 Oct; 62(20):5637-40. PubMed ID: 12384516
[TBL] [Abstract][Full Text] [Related]
17. Mutation and methylation of hMLH1 in gastric carcinomas with microsatellite instability.
Fang DC; Wang RQ; Yang SM; Yang JM; Liu HF; Peng GY; Xiao TL; Luo YH
World J Gastroenterol; 2003 Apr; 9(4):655-9. PubMed ID: 12679904
[TBL] [Abstract][Full Text] [Related]
18. Analysis of microsatellite instability, protein expression and methylation status of hMLH1 and hMSH2 genes in gastric carcinomas.
Gu M; Kim D; Bae Y; Choi J; Kim S; Song S
Hepatogastroenterology; 2009; 56(91-92):899-904. PubMed ID: 19621725
[TBL] [Abstract][Full Text] [Related]
19. Characterization of mutator pathway in younger-age-onset colorectal adenocarcinomas.
Roh SA; Kim HC; Kim JS; Kim JC
J Korean Med Sci; 2003 Jun; 18(3):387-91. PubMed ID: 12808326
[TBL] [Abstract][Full Text] [Related]
20. High-resolution methylation analysis of the hMLH1 promoter in sporadic endometrial and colorectal carcinomas.
Strazzullo M; Cossu A; Baldinu P; Colombino M; Satta MP; Tanda F; De Bonis ML; Cerase A; D'Urso M; D'Esposito M; Palmieri G
Cancer; 2003 Oct; 98(7):1540-6. PubMed ID: 14508843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
